These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30569527)

  • 1. Superficial CD34 positive fibroblastic tumor: report of three cases and review of the literature.
    Batur S; Ozcan K; Ozcan G; Tosun I; Comunoglu N
    Int J Dermatol; 2019 Apr; 58(4):416-422. PubMed ID: 30569527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case of recurrent superficial CD34-positive fibroblastic tumor.
    Salah HT; D'Ardis JA; Baek D; Duran J; Schwartz MR; Ayala AG; Ro JY
    J Cutan Pathol; 2023 Jun; 50(6):477-480. PubMed ID: 36107756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial CD34-positive fibroblastic tumor: Cytologic features, tissue correlation, ancillary studies, and differential diagnosis of a recently described soft tissue neoplasm.
    Li W; Molnar SL; Mott M; White E; De Las Casas LE
    Diagn Cytopathol; 2016 Nov; 44(11):926-930. PubMed ID: 27432164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superficial CD34-Positive Fibroblastic Tumor on the Chest Wall of an 8-Year-Old Girl: A Case Report and Literature Review.
    Li SY; Zhang HL; Bai YZ
    Pediatr Hematol Oncol; 2021 Sep; 38(6):602-608. PubMed ID: 33792506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superficial CD34-positive fibroblastic tumor (SCPFT): A review of pathological and clinical features.
    Salah HT; D'ardis JA; Baek D; Schwartz MR; Ayala AG; Ro JY
    Ann Diagn Pathol; 2022 Jun; 58():151937. PubMed ID: 35344860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superficial CD34-positive fibroblastic tumor: A new case from Japan.
    Wada N; Ito T; Uchi H; Nakahara T; Tsuji G; Yamada Y; Oda Y; Furue M
    J Dermatol; 2016 Aug; 43(8):934-6. PubMed ID: 26946226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superficial CD34-Positive Fibroblastic Tumor.
    Foot O; Hallin M; Bagué S; Jones RL; Thway K
    Int J Surg Pathol; 2020 Dec; 28(8):879-881. PubMed ID: 32608310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superficial CD34-Positive Fibroblastic Tumor: Two Case Reports.
    Yim JE; Kwon HM; Kim HR; Shin DH; Choi JS; Choi JH; Bae YK
    Ann Dermatol; 2023 May; 35(Suppl 1):S25-S29. PubMed ID: 37853859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superficial CD34-positive fibroblastic tumour: a clinicopathological and immunohistochemical study of an additional series.
    Lao IW; Yu L; Wang J
    Histopathology; 2017 Feb; 70(3):394-401. PubMed ID: 27636918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features of superficial CD34-positive fibroblastic tumor.
    Ding L; Xu WJ; Tao XY; Zhang L; Cai ZG
    World J Clin Cases; 2021 Apr; 9(12):2739-2750. PubMed ID: 33969057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial CD34-Positive Fibroblastic Tumor: Report of an Extremely Rare Entity.
    Zemheri E; Karadag AS; Yılmaz İ
    Indian J Dermatol; 2020; 65(6):526-529. PubMed ID: 33487713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superficial CD34-Positive Fibroblastic Tumor: A Newly Recognized Entity With Overlapping Features of PRDM10-Rearranged Soft Tissue Tumors.
    Shaker N; Abu Shakra R; Sangueza OP
    Cureus; 2023 Oct; 15(10):e47831. PubMed ID: 38021590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Superficial CD34-positive fibroblastic tumor: a clinicopathological analysis of 25 cases].
    Du XL; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2021 Dec; 50(12):1329-1334. PubMed ID: 34865419
    [No Abstract]   [Full Text] [Related]  

  • 14. Superficial CD34-Positive Fibroblastic Tumor Successfully Treated With Mohs Micrographic Surgery.
    Florek AG; Amin SM; Guitart J; Krunic AL
    Dermatol Surg; 2018 Feb; 44(2):313-315. PubMed ID: 28498203
    [No Abstract]   [Full Text] [Related]  

  • 15. Superficial CD34-positive fibroblastic tumor: A new entity; case report and review of literature.
    Sood N; Khandelia BK
    Indian J Pathol Microbiol; 2017; 60(3):377-380. PubMed ID: 28937375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superficial CD34-positive fibroblastic tumor: report of two cases and review of literature.
    Mao X; Sun YY; Deng ML; Ma T; Yu L
    Int J Clin Exp Pathol; 2020; 13(1):38-43. PubMed ID: 32055270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy.
    Carter JM; Weiss SW; Linos K; DiCaudo DJ; Folpe AL
    Mod Pathol; 2014 Feb; 27(2):294-302. PubMed ID: 23887307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired reactive digital fibroma: a clinicopathologic report of 5 cases of a new entity.
    Plaza JA; Suster S; Prieto VG; Sangueza M
    J Am Acad Dermatol; 2013 Oct; 69(4):603-8. PubMed ID: 23849562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial CD34-positive fibroblastic tumor in the forearm of a middle-aged patient: A newly described, rare soft-tissue tumor.
    Rekhi B; Banerjee D; Gala K; Gulia A
    Indian J Pathol Microbiol; 2018; 61(3):421-424. PubMed ID: 30004071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of SynCAM3 and cyclin D1 immunohistochemistry in distinguishing superficial CD34-positive fibroblastic tumor from its histological mimics.
    Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Murahashi Y; Emori M; Tsuyuki A; Hasegawa T
    Med Mol Morphol; 2023 Mar; 56(1):69-77. PubMed ID: 36344703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.